The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Pyankov S.A.

State Scientific Center of Virology and Biotechnology “Vector”

Shulgina I.S.

State Scientific Center of Virology and Biotechnology “Vector”

Rybel A.V.

State Scientific Center of Virology and Biotechnology “Vector”

Maksyutov A.Z.

State Scientific Center of Virology and Biotechnology “Vector”

Tyurin V.Yu.

State Scientific Center of Virology and Biotechnology “Vector”

Drachkova I.A.

State Scientific Center of Virology and Biotechnology “Vector”

Tregubchak T.V.

State Scientific Center of Virology and Biotechnology “Vector”

Bauer T.V.

State Scientific Center of Virology and Biotechnology “Vector”

Ovchinnikova A.S.

State Scientific Center of Virology and Biotechnology “Vector”

Odnoshevskiy D.A.

State Scientific Center of Virology and Biotechnology “Vector”

Kabanov A.S.

State Scientific Center of Virology and Biotechnology “Vector”

Bodnev S.A.

State Scientific Center of Virology and Biotechnology “Vector”

Pyankov O.V.

State Scientific Center of Virology and Biotechnology “Vector”

Agafonov A.P.

State Scientific Center of Virology and Biotechnology “Vector”

Application of A29L protein specific monoclonal antibodies a-A29L_MPoxV for monkeypox diagnosis

Authors:

Pyankov S.A., Shulgina I.S., Rybel A.V., Maksyutov A.Z., Tyurin V.Yu., Drachkova I.A., Tregubchak T.V., Bauer T.V., Ovchinnikova A.S., Odnoshevskiy D.A., Kabanov A.S., Bodnev S.A., Pyankov O.V., Agafonov A.P.

More about the authors

Journal: Molecular Genetics, Microbiology and Virology. 2023;41(4): 31‑37

DOI: 10.17116/molgen20234104131

Read: 1484 times

Download PDF (RU)
Contact the author
Table of contents

APPLICATION OF A29L PROTEIN SPECIFIC MONOCLONAL ANTIBODIES A-A29L_MPOXV FOR MONKEYPOX DIAGNOSIS
APPLICATION OF A29L PROTEIN SPECIFIC MONOCLONAL ANTIBODIES A-A29L_MPOXV FOR MONKEYPOX DIAGNOSIS

To cite this article:

Pyankov SA, Shulgina IS, Rybel AV, et al. . Application of A29L protein specific monoclonal antibodies a-A29L_MPoxV for monkeypox diagnosis. Molecular Genetics, Microbiology and Virology. 2023;41(4):31‑37. (In Russ.)
https://doi.org/10.17116/molgen20234104131

Подписка 2026 Молекулярная генетика, микробиология и вирусология (Molecular Genetics, Microbiology and Virology)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Inte­rcellular adhe­sion proteins: P-, E-, H-cadherins as onco­logical and cardiovascular diseases’ biomarkers. Russian Journal of Preventive Medi­cine. 2025;(7):100-105
Esta­blishing the dyna­mics of acti­vity and stability of total PSA samples in semen samples on gauze, dilu­ted with distilled water. Fore­nsic Medi­cal Expe­rtise. 2025;(5):39-42
Abstract:

INTRODUCTION

The spread of the disease caused by monkeypox virus (MPox) since 2022 has shown the urgency of developing countermeasures. The development of modern methods of clinical laboratory diagnostics of MPox contributes to this. Enzyme-linked immunosorbent assay (ELISA) is an accessible and sensitive platform for developing diagnostic tools. Detection of MPox antigens using ELISA kits based on monoclonal antibodies (MAbs) is promising due to quick time of analysis and minimal requirements for sample preparation.

MATHERIAL AND METHODS

We have developed and deposited two strains of Escherichia coli that produce recombinant proteins. Mice were immunized the AgPOX protein contains unique antigenic sequences of MPox. The Trx+A29 protein for selecting MAb producers includes the original amino acid sequence A29L. The absence of antibody crossover to Trx protein and native preparations of variola virus and vaccinia virus tested by ELISA. As a result of hybridization of splenocytes from immunized mice, MAb producers were obtained.

RESULTS

15 MAb-producing hybridomas were selected based on ELISA results with three specific MPox antigens and three non-specific ones. Three hybridomas were selected for deposit according to the productivity criteria. The possibility of detecting by its MAbs of the native MPox antigen at various concentrations was tested and method sensitivity was determined. The MAbs a-A29L_MPoxV of three hybridomas detected the native antigen MPox at a concentration of 102 PFU/ml. It is likely that the method is even more sensitive when selecting analysis conditions.

CONCLUSION

Based on labeled MAbs a-A29L_MPoxV, it is possible to develop a sensitive and specific indirect two-step ELISA kit for immunodiagnostics of MPox.

Keywords:

monkeypox virus
enzyme-linked immunosorbent assay
antigen
strain
hybridoma
monoclonal antibody

Authors:

Pyankov S.A.

State Scientific Center of Virology and Biotechnology “Vector”

Shulgina I.S.

State Scientific Center of Virology and Biotechnology “Vector”

Rybel A.V.

State Scientific Center of Virology and Biotechnology “Vector”

Maksyutov A.Z.

State Scientific Center of Virology and Biotechnology “Vector”

Tyurin V.Yu.

State Scientific Center of Virology and Biotechnology “Vector”

Drachkova I.A.

State Scientific Center of Virology and Biotechnology “Vector”

Tregubchak T.V.

State Scientific Center of Virology and Biotechnology “Vector”

Bauer T.V.

State Scientific Center of Virology and Biotechnology “Vector”

Ovchinnikova A.S.

State Scientific Center of Virology and Biotechnology “Vector”

Odnoshevskiy D.A.

State Scientific Center of Virology and Biotechnology “Vector”

Kabanov A.S.

State Scientific Center of Virology and Biotechnology “Vector”

Bodnev S.A.

State Scientific Center of Virology and Biotechnology “Vector”

Pyankov O.V.

State Scientific Center of Virology and Biotechnology “Vector”

Agafonov A.P.

State Scientific Center of Virology and Biotechnology “Vector”

Received:

28.09.2023

Accepted:

13.10.2023

Close metadata

References:

  1. Zhang Y, Zhou Y, Pei R, Chen X, Wang Y. Potential threat of human pathogenic orthopoxviruses to public health and control strategies. J Biosaf Biosecur. 2023;5(1):1-7.  https://doi.org/10.1016/j.jobb.2022.12.004
  2. Resolution of the Chief State Sanitary Doctor of the Russian Federation dated January 28, 2021 No. 4 “On approval of sanitary rules and norms SanPiN 3.3686-21 “Sanitary and epidemiological requirements for the prevention of infectious diseases”. (In Russ.). Accessed September 19, 2023. https://base.garant.ru/400342149/?ysclid=lmpx9sn6gb601578034
  3. Sklenovská N, Van Ranst M. Emergence of Monkeypox as the Most Important Orthopoxvirus Infection in Humans. Front Public Health. 2018;6:241.  https://doi.org/10.3389/fpubh.2018.00241
  4. Arita I, Henderson DA. Smallpox and monkeypox in nonhuman primates. Bull. World Health Organ. 1968;39:277-283. 
  5. Arita I, Jezek Z, Khodakevich L, Ruti K. Human monkeypox: A newly emerged orthopoxvirus zoonosis in the tropical rain forests of Africa. Am J Trop Med Hyg. 1985;34:781-789.  https://doi.org/10.4269/ajtmh.1985.34.781
  6. Di Giulio DB, Eckburg PB. Human monkeypox: an emerging zoonosis. Lancet Infect Dis. 2004;4:15-25.  https://doi.org/10.1016/S1473-3099(03)00856-9
  7. Huhn GD, Bauer AM, Yorita K, Graham MB, Sejvar J, Likos A, et al. Clinical characteristics of human monkeypox, and risk factors for severe disease. Clin Infect Dis. 2005;41(12):1742-1751. https://doi.org/10.1086/498115
  8. Marennikova SS, Shchelkunov SN. Orthopoxviruses pathogenic to humans. M.: Partnership of Scientific Publications KMK; 1998:38. (In Russ.).
  9. Likos AM, Sammons SA, Olson VA, Frace AM, Li Y, Olsen-Rasmussen M, Davidson W, Galloway R, Khristova ML, Reynolds MG, Zhao H, Carroll DS, Curns A, Formenty P, Esposito JJ, Regnery RL, Damon IK. A tale of two clades: monkeypox viruses. J Gen Virol. 2005;86(Pt 10):2661-2672. https://doi.org/10.1099/vir.0.81215-0
  10. Chen N, Li G, Liszewski MK, Atkinson JP, Jahrling PB, Feng Z, et al. Virulence differences between monkeypox virus isolates from West Africa and the Congo basin. Virology. 2005;340(1):46-63.  https://doi.org/10.1016/j.virol.2005.05.030
  11. Saijo M, Ami Y, Suzaki Y, Nagata N, Iwata N, Hasegawa H, et al. Virulence and pathophysiology of the Congo Basin and West African strains of monkeypox virus in non-human primates. J Gen Virol. 2009;90(Pt 9):2266-2271. https://doi.org/10.1099/vir.0.010207-0
  12. WHO. 2022-23 Mpox (Monkeypox) outbreak: Global Trends. Accessed October 02, 2023. https://www.who.int/publications/m/item/multi-country-outbreak-of-mpox--external-situation-report-28---19-september-2023
  13. Dyall J, Johnson RF, Chen DY, Huzella L, Ragland DR, Mollura DJ, et al. Evaluation of monkeypox disease progression by molecular imaging. J Infect Dis. 2011;204(12):1902-1911. https://doi.org/10.1093/infdis/jir663
  14. Dubois ME, Slifka MK. Retrospective analysis of monkeypox infection. Emerg Infect Dis. 2008;14(4):592-599.  https://doi.org/10.3201/eid1404.071044
  15. Ushkalenko ND, Ersh AV, Filatov PV, Poltavchenko AG. The rapid ELISA method for detection of orthopoxviruses. Problems of Virology. 2023;68(3): 242-251. (In Russ.). https://doi.org/10.36233/0507-4088-178
  16. Hughes LJ, Goldstein J, Pohl J, Hooper JW, Lee Pitts R, Townsend MB, et al. A highly specific monoclonal antibody against monkeypox virus detects the heparin binding domain of A27. Virology. 2014;464-465:264-273.  https://doi.org/10.1016/j.virol.2014.06.039
  17. Maniatis T, Fritsch EE, Sambrook J. Molecular cloning. Cold Spring Harbor lab. 1982.
  18. Reed LJ, Muench H. A simple method of estimating fifty per cent endpoints. American Journal of Epidemiology. 1938;27:493-497.  https://doi.org/10.1093/oxfordjournals.aje.a118408
  19. Chang TH, Chang SJ, Hsieh FL, Ko TP, Lin CT, Ho MR, et al. Crystal Structure of Vaccinia Viral A27 Protein Reveals a Novel Structure Critical for Its Function and Complex Formation with A26 Protein. PLoS Pathog. 2013;9(8):e1003563. https://doi.org/10.1371/journal.ppat.1003563
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.